
Moderna Shares Surge Over 100% on Historic Cancer Vaccine Breakthrough
Moderna's stock soared over 100% after its mRNA cancer vaccine with Merck achieved the first positive Phase 3 result. This breakthrough validates the mRNA platform beyond COVID-19 and could transform...























